MedTrace Logo

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

NCT06040567 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2025-04-06

No results posted yet for this study

Summary

The project aims to investigate the validity, and reliability of outcome measures of muscle strength, functioning (gait, balance, and fine motor skills), physical activity, and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy. Further, the project aims to compare physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills), and daily living among patients with polyneuropathy with physical activity and patient-reported outcome measures of functioning (gait, balance, and fine motor skills) and daily living in healthy adults.

Conditions

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Vasculitic Neuropathy
  • POEMS Syndrome
  • Multifocal Motor Neuropathy
  • Charcot-Marie-Tooth
  • hATTR Amyloidosis
  • Diabetic Polyneuropathy
  • Idiopathic Neuropathy
  • Polyneuropathies

Interventions

OTHER

Validity and reliability of outcome measures in polyneuropathy

Patients will be tested, answer patient reported outcome measures, and wear accelerometer at baseline after 2-4 weeks and after 1-2 years.

OTHER

Healthy controls

Healthy controls will be tested, answer patient reported outcome measures, and wear accelerometer at baseline visit. There is no follow-up in the healthy control group.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Britt S Pedersen · Rigshospitalet, University of Copenhagen

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-23
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06040567 on ClinicalTrials.gov